Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

Plumber, S. A., Tate, T., Al-Ahmadie, H., Chen, X., Choi, W., Basar, M., Lu, C., Viny, A., Batourina, E., Li, J., Gretarsson, K., Alija, B., Molotkov, A., Wiessner, G., Lee, B. H. L., McKiernan, J., McConkey, D. J., Dinney, C., Czerniak, B., & Mendelsohn, C. L. (2024). Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50678-2
Authors:
Sakina A. Plumber
Tiffany Tate
Hikmat Al‐Ahmadie
Xiao Chen
Woonyoung Choi
M. Murad Başar
Chao Lü
Aaron D. Viny
Ekatherina Batourina
Jiaqi Li
Kristjan H. Gretarsson
Besmira Alija
Andrei Molotkov
Gregory Wiessner
Byron Lee
James M. McKiernan
David J. McConkey
Colin P. Dinney
Bogdan Czerniak
Cathy Mendelsohn
Affiliated Authors:
Sakina A. Plumber
Tiffany Tate
Xiao Chen
M. Murad Başar
Chao Lü
Aaron D. Viny
Ekatherina Batourina
Jiaqi Li
Kristjan H. Gretarsson
Besmira Alija
Andrei Molotkov
Gregory Wiessner
James M. McKiernan
Cathy Mendelsohn
Publication Type:
Article
Unique ID:
10.1038/s41467-024-50678-2
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: